Penn Pharma wins Best in Class for Innovation
Pharmaceutical manufacturer Penn Pharma received a prestigious accolade at the annual CMO Leadership Awards, in New York this month winning Best in Class for Innovation
In 2013, Penn Pharma won three of the five possible CMO Leadership Awards for Innovation, Productivity and Regulatory and this year were entered into the newly introduced Best in Class Award for Innovation. Penn became eligible for this new award after receiving the highest perception score in this important category.
The awards, set up by Life Science Leader, were developed in response to the difficulties their readers encountered when vetting CMO partners. It recognises companies who achieve the top 20 percentile in perception scores.
US Business Development Executive, Mike Miller attended the event said: “It was an honour to be invited to participate in an evening that recognises superior performance in the CMO industry.”
Penn Pharma Chief Executive, Richard Yarwood added: “We pride ourselves on our commitment to innovation and to be recognised as Best in Class in this category proves that our hard work is being recognised.
"To be entered into these awards based on customer feedback is a great achievement and knowing that we are recognised for our innovation only strengthens our desire to continue to lead new developments in our industry sector.”
Vice President of Publishing, Life Science Leader, Jon Howland said: "The CMO Leadership Awards are a data driven award taking input from over 10,000 customers of CMO services. The Industry Choice Award recognizes the companies that these customers view as being the best in the respective categories. We congratulate the employees of Penn Pharma for being recognised with that honour."
Penn Pharma, based in Tredegar in Blaenau Gwent, South Wales delivers integrated drug development, clinical trial supply and manufacturing services to the international healthcare industry.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance